Akebia to Host Conference Call to Provide
CAMBRIDGE, Mass., Oct. 27,
2022 /PRNewswire/ -- Akebia Therapeutics,
Inc. (Nasdaq: AKBA), a biopharmaceutical company with the
purpose to better the lives of people impacted by kidney disease,
today announced plans to release its financial results for the
third quarter ended September 30,
2022 on Thursday, November 3,
2022 following the close of financial markets.
Akebia will host a conference call on Thursday, November 3 at 4:30 p.m. ET to discuss its financial results and
recent company highlights. To access the call by phone via a new
process, please click on this Registration Link and you will
be provided with dial in details. To avoid delays, we encourage
dialing into the conference call fifteen minutes ahead of the
scheduled start time.
A live webcast of the conference call will be available via the
Investors section of Akebia's website at: https://ir.akebia.com/.
An online archive of the webcast can be accessed via the Investors
section of Akebia's website at http://ir.akebia.com.
About Akebia Therapeutics
Inc. is a fully integrated biopharmaceutical company with the
purpose to better the lives of people impacted by kidney
disease. Akebia was founded in 2007 and is
headquartered in Cambridge,
Massachusetts. For more information, please visit our
website at www.akebia.com,
which does not form a part of this release.
Akebia Therapeutics Contact
View original content to download
SOURCE Akebia Therapeutics